Does VEDOLIZUMAB Cause Rectal haemorrhage? 2,163 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,163 reports of Rectal haemorrhage have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 2.9% of all adverse event reports for VEDOLIZUMAB.
2,163
Reports of Rectal haemorrhage with VEDOLIZUMAB
2.9%
of all VEDOLIZUMAB reports
80
Deaths
690
Hospitalizations
How Dangerous Is Rectal haemorrhage From VEDOLIZUMAB?
Of the 2,163 reports, 80 (3.7%) resulted in death, 690 (31.9%) required hospitalization, and 94 (4.3%) were considered life-threatening.
Is Rectal haemorrhage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VEDOLIZUMAB. However, 2,163 reports have been filed with the FAERS database.
What Other Side Effects Does VEDOLIZUMAB Cause?
Off label use (21,017)
Colitis ulcerative (13,455)
Crohn's disease (9,759)
Drug ineffective (8,424)
Diarrhoea (7,493)
Abdominal pain (6,401)
Fatigue (5,477)
Haematochezia (5,215)
Frequent bowel movements (4,527)
Arthralgia (4,028)
What Other Drugs Cause Rectal haemorrhage?
RIVAROXABAN (4,501)
ASPIRIN (3,057)
ADALIMUMAB (2,629)
INFLIXIMAB (1,554)
CLOPIDOGREL BISULFATE (1,333)
APIXABAN (1,177)
WARFARIN (1,174)
PREDNISONE (1,098)
MESALAMINE (990)
DABIGATRAN ETEXILATE (964)
Which VEDOLIZUMAB Alternatives Have Lower Rectal haemorrhage Risk?
VEDOLIZUMAB vs VELAGLUCERASE ALFA
VEDOLIZUMAB vs VELCADE
VEDOLIZUMAB vs VELETRI
VEDOLIZUMAB vs VELIPARIB
VEDOLIZUMAB vs VEMURAFENIB